Borrelia Bavarriensis 58

Borrelia Bavariensis p58 Recombinant
Cat. No.
BT28710
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Borrelia Bavarriens 58 produced in E.coli is a non-glycosylated, polypeptide chain having a calculated molecular mass of 61kDa.

Borrelia Bavarriensis 58 is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Borrelia is a genus of bacteria in the spirochete phylum. These bacteria are responsible for causing borreliosis, a zoonotic disease spread through vectors like ticks and lice, with the specific vector varying by species. There are 36 known Borrelia species, with 12 known to cause Lyme disease or borreliosis through tick bites. The primary species causing Lyme disease are Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. Borrelia bacteria possess a linear chromosome approximately 900 kbp in length, along with a multitude of linear and circular plasmids ranging from 5-220 kbp in size. Unlike typical bacterial plasmids, these contain numerous paralogous sequences, a high number of pseudogenes, and in some instances, essential genes. Notably, several plasmids exhibit characteristics suggesting they might be prophages.
Description
Recombinant Borrelia Bavarriens 58, produced in E.coli, is a non-glycosylated polypeptide chain with a calculated molecular mass of 61kDa. It is expressed with a -6x His tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear solution, sterile filtered.
Formulation
Borrelia Bavarriensis 58 is supplied in a buffer solution of 20mM HEPES (pH 7.6), 250mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Repeated freezing and thawing should be avoided.
Purity
Purity exceeds 80.0% as determined by SDS-PAGE analysis.
Immunological Functions
This protein exhibits the following immunological functions: 1. It can bind to both IgG and IgM type human antibodies. 2. It is suitable for use in immunodot tests with Lyme disease positive/negative plasma and in lymphocyte transformation tests (LTT).
Applications
This product can be used for Western blot analysis with patient samples.
Source
Escherichia Coli.

Product Science Overview

Introduction to Borrelia Bavariensis

Borrelia bavariensis is a species of bacteria belonging to the genus Borrelia, which is part of the spirochete phylum. This genus is known for causing borreliosis, a zoonotic, vector-borne disease transmitted primarily by ticks and, in some cases, by lice. Among the 36 known species of Borrelia, 12 are known to cause Lyme disease or borreliosis, with major species including Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, and Borrelia valaisiana .

The p58 Protein

The p58 protein is a significant antigen associated with Borrelia bavariensis. It plays a crucial role in the bacterium’s ability to infect and persist within its host. The p58 protein is often targeted in diagnostic assays and research studies due to its immunogenic properties.

Recombinant p58 Protein

Recombinant p58 protein from Borrelia bavariensis is produced using recombinant DNA technology. This involves cloning the gene encoding the p58 protein into an expression system, typically E. coli, to produce the protein in large quantities. The recombinant protein is then purified using various chromatographic techniques to ensure high purity and functionality .

Applications of Recombinant p58 Protein
  1. Diagnostic Assays: The recombinant p58 protein is used in ELISA (Enzyme-Linked Immunosorbent Assay) and other immunoassays to detect antibodies against Borrelia bavariensis in patient samples. This helps in the diagnosis of Lyme disease and other borreliosis-related conditions.
  2. Vaccine Development: Research is ongoing to explore the potential of the p58 protein as a vaccine candidate. Its immunogenic properties make it a promising target for developing vaccines to prevent Borrelia infections.
  3. Research Studies: The recombinant p58 protein is used in various research studies to understand the pathogenesis of Borrelia bavariensis, its interaction with the host immune system, and the development of new therapeutic strategies .
Production and Storage

The recombinant p58 protein is typically expressed with a hexa-histidine purification tag, which facilitates its purification using nickel-affinity chromatography. The protein is stored in a buffer with neutral to slightly alkaline pH and 20% glycerol as a cryoprotective agent. It is recommended to store the protein at -70°C or below to maintain its stability and prevent degradation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.